The OMB Uniform Guidance rule has provoked one of the most lopsided public backlashes in recent regulatory memory — and the numbers are not close.

Of roughly 51,000 comments posted to regulations.gov, about 94 percent oppose the proposal. Six percent support it. Fewer than one percent are ambiguous.

What the Rule Actually Does

On May 29, the White House Office of Management and Budget proposed a sweeping rewrite of 2 CFR Part 200 — the framework that has governed how federal agencies distribute grants, cooperative agreements, and financial assistance since 2013.

The stakes are enormous. More than $1 trillion in annual federal assistance flows through this framework, reaching:

• State and local governments
• Tribes
• Universities and research institutes
• Nonprofits and school districts
• Healthcare organizations
• Public authorities and small businesses

Roughly $150 billion of that total funds research and development, forming the backbone of American investment in science and technology.

The proposal would elevate what has been administrative guidance into binding, government-wide regulation, concentrating rulemaking authority inside OMB itself. Its most contested provisions would:

• Require political appointees to personally review all discretionary awards before issuance
• Expand agency authority to terminate active awards
• Restrict funding for collaborations with certain foreign entities

The Scientific Community Sounds the Alarm

The reaction from research institutions was immediate and severe.

In a June editorial titled “Another red alert for American science,” Science Editor-in-Chief Holden Thorp argued the rule amounts to an end-run around congressional intent and a mechanism for starving federal research. By inserting political review directly into the funding pipeline, he wrote, the rule effectively supersedes scientific peer review.

His central warning: handing political appointees the power to select, cut, or terminate research awards converts independent research allocation into an instrument of executive policy.

Professional bodies mobilized. The American Physical Society and the American Geophysical Union both built platforms to help members draft and submit comments.

Who Actually Wrote In

The composition of the opposition is perhaps its most notable feature — because it was not manufactured.

Form letters accounted for only about 16 percent of all comments, roughly 8,400 submissions spread across 210 distinct campaigns. Just one in eight opposing comments came from a form-letter campaign.

Support tells the opposite story. Nearly nine in ten supportive comments — about 2,500 of them — originated from a single form-letter campaign.

In other words: opponents largely wrote their own words. Supporters largely signed someone else’s.

The commenter breakdown:

• About 39,000 (77 percent) from unaffiliated individuals
• Roughly 7,900 from individual researchers and academics
• About 3,300 from patients, families, and health advocates
• Around 280 advocacy nonprofits
• Roughly 70 scientific and professional societies
• About 30 universities and research institutions

At least 14 elected officials’ offices submitted letters of opposition, including one from Rep. Jamie Raskin carrying 125 co-signers.

What They Objected To

Two themes dominate the record.

Politicization of grant decisions appeared in roughly two-thirds of all comments. The sidelining of scientific peer review surfaced in more than half.

One federally funded scientist put the concern bluntly, writing that having scientists vet projects is the core of a nonpartisan program, and that allowing partisan non-scientists to exercise oversight is a mistake research communities would need generations to recover from.

The American Society of Naturalists focused on the mechanics, warning that the rule would compel senior political appointees to personally review and approve every discretionary research grant for consistency with presidential policy priorities.

A physician-researcher named the specific provision — §200.205 — noting it would let a political appointee override the outcome of scientific peer review entirely.

Not Just a Science Fight

Some of the sharpest objections had nothing to do with laboratories.

The Southern Environmental Law Center attacked the process itself, arguing that 45 days is an inadequate comment window for a rule exceeding 400 pages that binds 41 federal agencies.

A food-bank volunteer raised the economic blind spot, noting the proposal touches well over $1 trillion in annual grants, affects every state and tribe and most major nonprofits, universities, and hospitals — and that OMB has not attempted to quantify the impact on any of them. Small local food banks, the commenter feared, would simply get lost in the new structure, leaving thousands hungry.

Notably, OMB’s own regulatory review office determined the rule was economically non-significant.

What Supporters Said

The supportive comments were both fewer and narrower.

Almost all of the roughly 2,900 cited preventing waste, fraud, and abuse — and little else. The Immigration Accountability Project, for instance, praised the new E-Verify requirement for grant recipients.

The handful of supporters who wrote original comments were more measured. The City of Lago Vista, Texas, backed improved oversight of federal spending while cautioning that reimbursement procedures should not unnecessarily delay payments.

The Provisions Drawing Fire

Comments clustered tightly around specific sections:

• §200.205 (political pre-issuance review): cited in about 6,900 comments
• §200.340 (expanded termination authority): about 5,900
• §200.461 and §200.432 (limits on allowable costs): each cited more than 3,000 times

What Happens Now

Under notice-and-comment rulemaking, OMB is legally obligated to review these submissions and respond to every substantive argument before finalizing the rule.

That obligation collides with an aggressive timeline. Comments closed July 13. The proposed effective date is October — leaving only weeks to process tens of thousands of substantive objections, with more than 200,000 additional comments received but not yet published.

There may also be a further avenue for public input. Under Executive Order 12866, interested parties can request meetings with OMB once final regulatory review begins. Those watching should monitor reginfo.gov.

The Bottom Line

Tens of thousands of scientists, clinicians, and ordinary citizens sat down and wrote, in their own words, to tell OMB the same thing: putting political appointees in charge of which research gets funded would corrode both the quality and the independence of American science.

Whether that record changes anything is now entirely up to the agency it was addressed to.